
Pomerantz Law Firm Alerts Shareholders of Ipsyerena Therapeutics (INCY) with Losses: Class Action Lawsuit Deadlines Nearing
Class Action Lawsuit Filed Against Kyverna Therapeutics: What Does It Mean for Investors and the World? In the bustling heart of New York City, amidst the towering skyscrapers and the relentless hum of commerce, a significant legal development unfolded on January 22, 2025. Pomerantz LLP, a renowned securities law firm, announced the filing of a…